Bill > S04501

This bill allows licensed pharmacists to initiate treatment for COVID-19, influenza, and Group A streptococcal pharyngitis (a specific type of throat infection) after conducting a positive test, following a statewide protocol developed by the Department of Health. The protocol requires pharmacists to ensure patient safety, maintain proper records, and provide referrals for continued care. When initiating treatment, pharmacists must ask patients about their primary care provider and maintain an updated list of local healthcare providers. The Department of Health will create and maintain a searchable online list of primary care providers, highlighting those recognized as patient-centered medical homes (PCMH) and including providers who serve Medicaid, low-income, uninsured, and disabled patients. Pharmacists must document the test result and treatment, and typically report this information to the patient's designated healthcare provider, unless the patient directs otherwise. The bill will take effect immediately and is set to expire on April 1, 2028, providing a temporary expansion of pharmacists' treatment capabilities during the specified period.

Education

https://www.nysenate.gov/legislation/bills/2025/S4501